SMYD5 and sarcoma: However, SMYD5 expression data for normal tissues were not available for several cancers in TCGA, such as adrenocortical carcinoma (ACC), diffuse large B-cell lymphoma (DLBC), acute myeloid leukemia (LAML), lower-grade glioma (LGG), ovarian cancer (OV), sarcoma (SARC), testicular germ cell tumors (TGCT), thymoma (THYM), uterine corpus endometrial carcinoma (UCEC), and uterine carcinosarcoma (UCS).